Q2 FY2026 EarningsQ2 FY2026 results exceeded consensus across major metrics, with revenue of $321.4M beating the $309.6M expected and Adjusted EPS of $0.26 surpassing the $0.24 mean. Nordion led segment performance with 16.7% constant currency growth driven by Cobalt-60 harvest timing. Management significantly raised FY2026 guidance, projecting revenue growth of 5.25%-6.75% and Adjusted EPS of $0.95-$1.01, reflecting strong AI-adjacent healthcare demand and improved operational leverage.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Sotera Health(SHC) the Revenue is 321.38 M (+9.18%), Beat estimate;the EBIT is 137.97 M (+8.04%), Beat estimate;the EPS is 0.19 (+533.3%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.32B9.18%
0.31B5.17%
+0.01B4.01%
EBITExceed expectations
0.14B8.04%
0.13B3.15%
+0.01B4.89%
EPSExceed expectations
0.19533.33%
0.1667455.57%
+0.023377.76%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf